Prenetics Ltd - PRE STOCK NEWS

Prenetics' IM8 Health has expanded its Scientific Advisory Board (SAB) with the addition of two distinguished members: Dr. Jeremy London, a board-certified cardiothoracic surgeon with 25+ years of experience, and Dr. Amy Shah, a double board-certified expert in Internal Medicine. They join an existing prestigious team from institutions including Mayo Clinic, NASA, Cedars-Sinai, and Yale University.

The expanded SAB supports IM8's flagship product, Daily Ultimate Essentials, a clinically-validated all-in-one daily powder supplement designed to replace up to 16 supplements. The product focuses on energy, immunity, digestion, and longevity, featuring NSF certification for Sport.

This strategic expansion occurs as the global supplements market, currently valued at $152 billion, is projected to reach $300 billion by 2028, driven by increasing demand for scientifically-backed products.

Prenetics Global (NASDAQ: PRE), a leading consumer health sciences company, has announced its participation in the 37th Annual ROTH Conference. The event will take place from March 16th to March 18th, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA.

CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings with investors. Additionally, management will join a panel discussion focused on Longevity and Supplementation on Monday, March 17th at 12:00pm PT. The panel discussion will be accessible via webcast and will be available on Prenetics' investor relations website.

Prenetics (NASDAQ: PRE) reported strong Q4 and full year 2024 results, with Q4 revenue growing 93.5% to $10.5 million and full-year revenue increasing 40.9% to $30.6 million. The company maintains a solid financial position with $84.8 million in cash and short-term assets.

Key highlights include:

• Gross profit from continuing operations reached $4.6 million in Q4 2024 (up 73.1%) and $16.1 million for full-year 2024 (up 82.6%)
• Full-year gross margin improved to 52.6% from 40.6% in 2023
• IM8 Health launch showed promising results with $106 average order value and 83% subscription rate

For 2025, Prenetics projects revenue of $73-85 million, representing 350-450% year-over-year growth. The company expects to achieve profitability by Q4 2025, focusing on consumer health brands IM8, Europa, and CircleDNA.

Prenetics Global (NASDAQ: PRE) has announced a strategic partnership with Humanity Protocol to integrate its CircleDNA service for blockchain-based identity verification. The collaboration aims to provide secure Proof of Personhood credentials using DNA testing and zero-knowledge proof technology.

The company has established a Crypto Strategic Reserve with initial investments of $1.5M distributed across $H tokens ($1M), Bitcoin ($250K), and Solana ($250K). These investments will be reviewed quarterly. Prenetics reported $84.87M in cash and short-term assets as of December 31, 2024.

Additionally, through its joint venture Insighta, Prenetics is advancing in decentralized science (DeSci) with AI-driven early cancer detection, supported by a $30M investment from Tencent. The company's consumer health brand, IM8, is also contributing to DeSci initiatives by applying scientific advancements to daily health and longevity solutions.

IM8, a premium supplements brand co-founded by David Beckham, celebrated its U.S. launch with events in New York City on January 14, 2025. The launch featured two main segments: an Inside Out Wellness session with Deepak Chopra and Beckham, and an evening event with the Scientific Advisory Board.

The wellness session included tasting of IM8's Daily Ultimate Essentials product and a meditation session. The evening featured panel discussions with medical experts and a conversation between Beckham and Fast Company's Jeff Beer about his involvement with IM8.

The company reported increased customer interest following Beckham's TODAY Show appearance and influencer coverage. The brand's Daily Ultimate Essentials product recently received NSF Certified for Sport® certification, validating its safety and quality standards.

Prenetics' IM8, a premium supplements brand co-founded by David Beckham, has announced that its flagship product, Daily Ultimate Essentials, has received NSF Certified for Sport® certification. This prestigious certification validates the product's safety, quality, and transparency through rigorous testing of over 280 banned substances, heavy metals, pesticides, and contaminants.

The certification ensures compliance with major athletic organizations including WADA, MLB, NFL, NBA, and PGA. Every production batch undergoes testing to maintain consistency and quality. The product is designed as an all-in-one formula replacing 16 supplements with 92 nutrient-rich ingredients.

IM8 Daily Ultimate Essentials is priced at US$79 for subscription ($99 one-time) and ships to 31 countries. The company is offering a welcome launch package including a signature red cup and five travel sachets valued at US$46.

Prenetics' IM8 has announced a collaboration with Mayo Clinic to develop a new line of premium supplements, focusing on nutrition, cellular rejuvenation, protein, collagen, and overall wellness. The partnership, announced after IM8's official launch on November 18th on IM8health.com, combines IM8's innovation with Mayo Clinic's medical expertise to create evidence-based, clinically researched supplements.

The collaboration includes contributions from Dr. Dawn Mussallem, a Mayo Clinic integrative oncologist who serves on IM8's Scientific Advisory Board. Mayo Clinic maintains a financial interest in the referenced technology and will direct any revenue toward its not-for-profit mission in patient care, education, and research.

Prenetics' IM8 has launched a groundbreaking space experiment aboard the International Space Station (ISS) in collaboration with the University of Oxford, supported by Space Applications Services. The mission, launched via SpaceX CRS-31 on November 4th, aims to study accelerated aging and longevity using microgravity's unique environment.

The experiment focuses on autophagy, the cellular process of removing and recycling damaged components, using 3D organoids in a specially designed science cube. The research leverages microgravity's ability to accelerate aging processes, potentially leading to insights for improving human healthspan and astronaut health.

Coinciding with this research, IM8 officially launched its premium supplements brand on November 18th on IM8health.com, offering two products: Daily Ultimate Essentials and Daily Ultimate Longevity, now shipping to 31 countries.

Prenetics Global (NASDAQ: PRE) has announced its participation in two upcoming investor conferences in December 2024. The company will attend the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, where CEO Danny Yeung will present on December 10 at 10:00am ET, followed by one-on-one meetings with CFO Stephen Lo and Prenetics Americas President David Vanderveen on December 11.

Additionally, David Vanderveen will represent the company at the 13th Annual ROTH Deer Valley Event in Park City, UT from December 11-13, conducting one-on-one investor meetings throughout the conference.